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Summary Histopathological assessment of formalin-fixed biopsy tissue and surgical resection 
specimens remains the cornerstone of cancer diagnosis and pathological staging in routine 
clinical practice. In recent years, standard protocols for reporting head and neck cancer have 
been widely used and these have improved the general level of the pathological assessment. 
In this article, we look beyond the standard protocols and deal with potential difficulties and 
pitfalls in the assessment of incisional biopsy specimens, surgical resection specimens and 
neck dissections. We draw attention to possible shortcomings and issues requiring 
clarification. Emphasis is given to precise histopathological definitions, histopathological 
detection and differential diagnosis. The approach is a practical one - a consideration of 
common experiences and dilemmas faced by the reporting pathologist, and where possible, 
we offer guidance and practical tips. The article concludes with a brief consideration of the 










Although, molecular biology is being increasingly used in the investigation of oral and 
oropharyngeal squamous cell carcinoma (OSCC), histological assessment of 
surgically-removed formalin-fixed tissues remains the cornerstone of its diagnosis 
and pathological staging in routine clinical practice. In recent years, standardised 
pathological protocols1 and regular multidisciplinary team meetings (MDTs) have 
become routine and are essential for a high quality service. Nevertheless, problems 
may occur at all stages of the histopathological diagnosis and staging, from the 
processing of received tissues to the generation of the final report. They may result 
from inherent limitations of histopathological definitions, diagnosis and staging; 
inaccuracies in histological detection and histological misinterpretation. The present 
article concentrates on such problems. Our aims were: 1) to illustrate potential pitfalls 
by considering common experiences during the pathological assessment of the initial 
and subsequent diagnostic / incisional intra-oral biopsy specimens, surgical resection 
specimens (Fig. 1) and neck dissections (NDs) (Fig. 2); 2) to draw attention to 
possible shortcomings and issues needing clarification; and 3) to suggest, where 
possible, practical solutions, improvements and areas of further research. Finally, the 
impact of detailed, accurate pathological staging in prognosis prediction of OSCC is 
considered. 
 
2. Problems related to incisional biopsies and surgical resections of 
primary OSCCs 
 
Questions and potential problems are expected to arise when the pathologist 
assesses incisional biopsies and surgical resections of the primary tumour. Some of 
the questions and experiences overlap, while others merit only brief consideration, 
and hence, some of the situations can be grouped and addressed in conjunction. 
Table 1 summarises the groupings and indexes the topics which we discuss. 
 
2.1 Proliferative squamous epithelial dysplasia 
 
Similarly to actinic cutaneous keratosis,2 we tend to designate a dysplastic lesion as 
‘proliferative’ when increased epithelial thickness is present. The late life history of 
such lesions is uncertain. 
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2.2 Histological subtypes of OSCC  
 
In addition to the conventional and instantly recognised OSCC, several subtypes 
presenting varying diagnostic challenges have been recognised.3 While some are 
addressed here it was deemed appropriate to discuss the remainder in other sections 
(see Table 1). It is not our intention to repeat descriptions in standard references3 
and emphasis is given to personal approaches, experience and observations. 
The OSCC subtypes often occur alone (‘pure’ forms). However, ‘hybrid’ 
OSCCs, combining varying ratios of more than one subtypes, are now being 
increasingly recognised and are attributable to proliferation of individual clones 
expressing different phenotypes. Cervical node metastases of hybrid OSCCs may 
consist wholly or predominantly of one subtype. 
It has been repeatedly stated that the acantholytic SCC could be 
misdiagnosed as adenocarcinoma, adenosquamous carcinoma, and 
mucoepidermoid carcinoma.4 With awareness and increased experience the prompt 
recognition of the subtype is not difficult, particularly when it is considered that the 
acantholytic changes, which result in the formation of pseudolumens / 
pseudoglandular spaces (Fig. 3), are usually not extensive and asymmetrically 
distributed, preferentially close to the advancing front of the tumour. The presence of 
malignant acantholysis within surface dysplastic epithelium and experience with 
cutaneous SCCs wherein the acantholytic subtype is more often seen would be of 
further help. The recognition can be confirmed by special staining for 
mucosubstances, eg. Alcian Blue (AB) pH 2.5 followed by periodic-acid/Schiff (PAS), 
as these are absent from pseudolumens. Malignant acantholysis usually affects the 
central part of advancing cellular aggregates and a ‘basal’ layer is preserved (Fig. 3). 
We have, however, observed tumours where the latter becomes focally affected and 
dyscohesive. This results in collections of malignant keratinocytes occurring as 
individual units subadjacent to the advancing front, which can be highlighted by 
immunohistochemistry for cytokeratins (using a panel of pan-keratin antibodies) (Fig. 
4). We do not report these as acantholytic SCCs, but as conventional SCCs with 
dyscohesive foci at the advancing front. It is not known whether this phenomenon is 
of prognostic significance, but see section 2.3. 
Considerable difficulties could arise when the malignant acantholysis affects 
most of the tumour and the histology becomes that of individual cells of variable / 
‘bizarre’ phenotypes, which are extensively insinuating between normal tissue 
elements rather than the cellular aggregates with pseudoluminal arrangements seen 
in typical acantholytic SCC. Increased index of suspicion and immunohistochemistry 
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for cytokeratins would overcome the difficulties. We are characterising these as non-
cohesive SCCs, but we are unable to comment on prognostic significance, because 
they are rare (see section 2.3). 
In the context of non-cohesive SCCs, we have to consider the 
pseudovascular SCC that can be mistaken for angiosarcoma and the giant cell 
carcinoma of the mouth. Immunohistochemistry for cytokeratins and endothelial 
markers would be helpful in recognising the former,5 whereas the very rare giant cell 
carcinoma may show multinuclear cells resembling osteoclasts or pleomorphic giant 
cells.3 When this presents in the mouth, it is important to exclude a metastasis from, 
for example, thyroid or lung, the usual sites of giant cell carcinoma.6 
Aptly named, the basaloid SCC (Fig. 5) is characterised by ‘basaloid’ cell 
phenotypes and variable peripheral palisading.3 It can bear a resemblance to 
ameloblastoma, which could cause confusion for tumours centred on the alveolar 
processes, and occurs either as pure or hybrid forms (Figs. 5, 6). This could be a 
confounding factor in studies attempting to ascribe different grades to particular 
subtypes and it is conventionally accepted that basaloid SCCs are of a worse 
prognosis (see section 4.1.8). 
The diagnostic challenges presented by spindle cell carcinoma (Fig. 7) are 
well known and, although mandatory, immunohistochemistry is not consistent. 
Cytokeratin immunoreactivity is often focal or variable (40-85%)7 and it is essential to 
use a panel of antibodies. The need for careful search for a surface origin, epithelial 
dysplasia or foci with discernible squamous / squamoid phenotypes has been 
emphasised, but an incisional biopsy could be lacking such features and a high index 
of suspicion to prompt further investigation is a sine qua non for mistakes to be 
avoided. Myofibroblastic reactions (Fig. 8) and the ‘bizarre’ stromal cells often seen in 
florid granulation tissue, occasionally following previous biopsy, or at sites following 
radiotherapy such as brachytherapy, have also been considered as possible 
diagnoses when biopsies show ‘suspicious spindle cells’.8.9 We feel, however, that 
the recognition of these cells is less difficult than that of malignant keratinocytes 
showing spindled or ovoid phenotypes and occurring as individual units. 
Myofibroblasts often have discernible borders, eosinophilic cytoplasm, fascicular 
arrangement, low mitotic activity and, if any doubt, immunoreactivity for smooth 
muscle actin (SMA) (Fig. 7b), whereas the ‘bizarre’ stromal cells, in comparison with 
malignant keratinocytes, are usually elongated and lack rounded / ‘epithelioid’ 
phenotypes (Fig. 7b). 
Intra-oral carcinomas may show a variable component exhibiting features 
similar to the nasopharyngeal non-keratinising carcinoma10 with a lympho-
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plasmacytic inflammatory infiltrate. When the latter is brisk, the designation 
‘lymphoepithelial carcinoma’ may be preferred. The histology is distinctive and 
comprises sheets and cellular masses composed of cells with ill-perceived borders 
(resulting in the characteristic ‘syncytial’ arrangement),10 and vesicular nuclei with 
obvious nucleoli (Fig. 9). 
Apart from the nasal cavity and paranasal sinuses, carcinomas showing a 
transitional phenotype may arise as primaries in oral / oropharyngeal sites, eg. the 
base of tongue (Fig. 10a) and tonsil.11 Keratinisation is absent or minimal (occasional 
small and poorly-formed keratin pearls or squamous ‘eddies’) and a correct diagnosis 
should be prompted by the distinctive histology. This comprises multilayered cellular 
masses in characteristic garland- or ribbon-like arrangements (Fig. 10b), which are 
usually affected by central comedo-necrosis, surrounded by variably discernible 
basement membrane and composed of mitotically active non-keratinising cells that, 
peripherally, may have their long axis oriented vertical to the underlying basement 
membrane (Fig. 10c). Pure or hybrid forms are seen (Fig. 11). 
Finally, the rare pigmented intra-oral carcinomas12 are histopathological 
curiosities rather than of clinical significance. They correspond to conventional SCCs 
that have been ‘colonised’ by dendritic melanocytes synthesising and transferring 
melanin to adjacent malignant keratinocytes (Fig. 12). The phenomenon is similar to 
that seen in basal cell carcinomas, adnexal tumours and Bednar’s tumour.13 
Although many subtypes of SCC are considered rare or very rare in the 
mouth and oropharynx, we believe that they will become increasingly recognised with 
centralisation of cancer services and sharing of cases between oral and Ear Nose 
and Throat (ENT) pathologists. Although currently sub-typing may be considered 
largely ‘academic’, it is essential that it is accurate and well documented so that 
information on management and prognosis can be shared (see section 5.1.8). 
 
2.3 Grading systems of conventional OSCC, growth patterns and 
measurements 
 
The histopathological grading of conventional OSCC as well- (pG1), moderately- 
(pG2) or poorly differentiated (pG3),14 enjoys popularity because it is simple. The 
degree of ‘differentiation’ (resemblance to normal oral / oropharyngeal surface 
epithelium) is subjectively assessed and in terms of keratinisation, cellular 
pleomorphism, mitotic activity and nuclear aberrations.14 Application of the system, 
which evolved from Broders’ original classification15, indicates that > 50% of oral and 
> 90% of oropharyngeal SCCs are moderately differentiated.14 Increased 
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discrimination is, however, desirable and the World Health Organisation (WHO) is 
now recommending that grading by differentiation is supplemented by assessment of 
the pattern of invasion. Hence, it is important that an incisional biopsy is of sufficient 
size and depth to include part of the advancing front of the tumour. Ideally, the deep 
front should be included, but if not, as in large tumours, the peripheral (lateral) front is 
often sufficiently representative to allow provisional assessment. 
Four patterns of invasion have been described depending on the degree of 
keratinocyte dyscohesion (decreased intercellular cohesion / loosening of 
keratinocytes).1 Different regions of the same tumour often show different patterns of 
invasion, but the most aggressive pattern is recorded. The type-I pattern corresponds 
to tumours where the constituent cells retain cohesion and are arranged as broad, 
bands and columns, occasionally bulbous, which tend to penetrate at more or less 
the same level; this results in a rather defined, although asymmetrical, ‘pushing’ or 
‘expansive’ advancing front. The type-II pattern is characterised by the arrangement 
of malignant keratinocytes as islands or sheets, rounded, irregular or spiky, which are 
asymmetrically distributed and penetrate at different levels; this results in an irregular 
tumour silhouette. The type-III pattern resembles type II as regards the tumour 
silhouette, but dyscohesion, in the form of tiny islands and cords that bud off from the 
larger islands and sheets, extensively affects the advancing front here (Fig. 13). The 
type-IV pattern corresponds to the archetypal non-cohesive tumours wherein the 
irregular advancing front shows malignant keratinocytes infiltrating as individual units 
because of loss of intercellular cohesion (Figs. 14-16). Except for irregularity, the 
advancing front becomes variably defined in types III and IV and ‘satellite elements’ 
ahead of it are often seen. We wonder, however, whether these types should be 
further sub-typed in terms of the extent of dyscohesion / loss of cohesion. For 
example, when these processes are mainly affecting the advancing front, the 
tumours should be categorised as type IIIa and IVa respectively. On the other hand 
when the processes affect most of, or the entire tumour mass, tumours becoming 
thus ill-defined and composed of tiny islets and spidery cords or single cells, the 
grading should be IIIb and IVb. In this vein, the conventional SCCs with dyscohesive 
foci at the advancing front and the non-cohesive SCCs, which were noted in section 
2.2, could be included in the types IVa and IVb respectively. Whether such sub-
typing is merely academic or has a prognostic significance remains to be seen. 
Multifactorial grading systems, such as that suggested by Anneroth and 
Hansen 16 and modified by Bryne et al.17, select the most ‘worrisome’ / ‘unfavourable’ 
region of the advancing front for assessment, consider features of both tumour cells 
and the tumour-host interface, and score each feature on a scale of 1 to 4, to give a 
 8 
total malignancy score ranging from 4 to 24 or 28. Keratinisation, nuclear aberrations 
(Fig. 13) and mitoses are considered in the assessment of the tumour cells, whereas 
the tumour-host interface is assessed in terms of the pattern and level of invasion, 
and the inflammatory-cell reaction. Multifactorial systems are preferable to grading by 
differentiation, but discrimination is still not ideal. Application of such a system in a 
series of conventional T2 SCCs of tongue resulted in total scores clustered around a 
median of 20.5 for tumours with metastasis and 16.5 for tumours without 
metastasis.18 
In comparison with the system introduced by Clark et al.19 for the 
histopathological grading of cutaneous malignant melanoma, the conventional OSCC 
multifactorial systems do not recognise the superficial vascular plexus as a separate 
level of invasion and do not distinguish between ‘brisk infiltrative’ and ‘brisk non-
infiltrative’ patterns of the inflammatory reaction. We have observed both patterns in 
our material (Figs. 13, 17) and occasionally noted an association of brisk and 
infiltrative inflammation with extensive / massive apoptosis of tumour cells (Fig. 17). 
The significance of infiltrative and non-infiltrative inflammation, particular 
inflammatory-cell types, like eosinophils (Fig. 18), and extent of apoptosis in the 
histopathological grading of OSCC might be worth pursuing. 
Except for the pattern and cellular composition of the inflammatory reaction, 
the presence or absence of tumour-induced (desmoplastic, ‘reactive’ according to 
Reed20) stroma has not been considered in the conventional OSCC grading systems. 
Desmoplastic stroma can be seen in both the primary tumour and metastases and 
comprises an increased number of stromal cells, for example fibroblasts or 
myofibroblasts, which are often arranged parallel to the contour of tumour-cell 
aggregates and are variably mixed with fibrillary collagen or glycosaminoglycans, and 
often shows little or no inflammation (Figs. 19, 20). Although the formation of tumour-
induced stroma (‘desmoplasia’) is pivotal in tumourigenesis and metastasis21 it has 
received little attention in OSCCs.22 
Regardless of possible shortcomings we recommend the routine use of 
multifactorial grading while reporting on conventional OSCCs and we also record 
desmoplasia, lymphovascular invasion (see section 2.5) and peri- / endoneural 
invasion (Fig. 21). Lymphovascular and / or neural invasion can be seen in stroma 
between tumour-cell aggregates and adjacent to or ahead of the main invasive front 
(see Fig. 9 in Woolgar and Triantafyllou23). However, it is the latter that should be 
meticulously sought because of its prognostic significance (see section 5.1.4) and 
inclusion in measurements of the width of the surgical margin (see below). 
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When assessing the size of an OSCC, the macroscopic appearances and 
growth pattern need to be considered. Although measurement of tumour volume is 
the most accurate indicator of the tumour size, the UICC staging procedure started 
out as a clinical assessment of the extent of disease, and hence, the surface greatest 
diameter was the obvious indicator of tumour size.24 The pathological TNM stage 
uses exactly the same criteria and categories as clinical staging. In assessing the 
surface diameter histologically, only invasive carcinoma should be included.24 In 
addition to measuring the surface diameter and given the importance of the Breslow 
thickness in the prognosis of cutaneous malignant melanoma,19, 25 it was gradually 
appreciated that the tumour thickness of an OSCC should be also recorded. In 
OSCCs, however, the reconstructed tumour thickness (Fig. 22), which compensates 
for an exophytic growth component or ulceration and tissue destruction, is 
considered a better prognosticator than the actual (Breslow) tumour thickness.26 
(Note that in the case of endophytic tumours, the reconstructed thickness coincides 
with the actual thickness and that ‘depth of invasion’ is an alternative term for 
reconstructed thickness.) Care should be taken to ensure that any tumour cells 
(including lymphovascular emboli and neural spread) ahead of the main invasive 
front are included.1 The Vernier of the stage of the microscope or a graticule can be 
used for the measurements. 
Occasionally, OSSCs have no obvious invasive front. They consist or thin 
spidery cords only detectable histologically23 or correspond to the dyscohesive 
tumours described in section 2.2. Measuring these tumours can cause practical 
difficulties as do large tumours, tumours consisting of widely distributed multiple 
blobs or nodules (Fig. 23) and tumours covering more than one anatomical region or 
involving anatomical curvatures. In such cases, the final recorded measurements 
should be based on the macroscopic measurement supplemented by microscopic 
assessment of immunohistochemical preparations and tissue blocks, which would 
allow highlighting or reconstruction (see section 3.2) of the tumour silhouette 
respectively. 
Except for surface diameter and reconstructed thickness the distance of 
tumour to nearest deep and mucosal resection margins should be measured (see 
sections 3.3 and 5.1.9, and Woolgar and Triantafyllou23). 
 
2.4 Deep (unequivocal) vs. superficial (early / minimal) invasion 
 
The diagnosis of OSCC is usually straightforward when there is unequivocal 
invasion together with cytological atypia. Detecting islands, cords and other 
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arrangements of squamoid epithelial cells, which are not salivary or odontogenic (see 
sections 2.6, 2.7 and 2.9), in submucosal tissues such as skeletal muscle, fat or 
salivary lobules (Fig. 24), or in bone marrow spaces qualifies as unequivocal 
invasion. This criterion is particularly helpful: 1) when epithelial islands or cords are 
detected in submucosa below merely dysplastic surface epithelium (Fig. 25); and 2) 
in the recognition of carcinoma cuniculatum.27 The latter is characterised by tortuous 
centrally-keratinising columns of proliferated squamous epithelium with minimal 
cytologic atypia, which are meandering between skeletal muscle fibres or residual 
bone trabeculae (Fig. 26). When unequivocal invasion is established, an origin with 
dysplastic surface epithelium confirms the primary nature of the lesion and this 
should be sought by step and serial sectioning if not immediately apparent. However, 
this may not be possible in incisional biopsies and extensively ulcerated tumours and 
re-biopsy could be an option. Additional problems may arise due to insufficient 
sampling (either at the macroscopic assessment and trimming stage or insufficient 
sampling of the block) or poor orientation of the tissue within the block. 
When unequivocal / submucosal invasion cannot be established, the question 
of ‘early SCC’ arises. The major problem here is deciding whether or not frank 
invasion of the lamina propria is present. Difficulties increase on incisional biopsies 
showing proliferative, moderate or severe squamous epithelial dysplasia (see section 
2.1). 
‘Islands’ of epithelium within the lamina propria should be regarded as 
suspicious, but it is important to exclude whether they represent sectioned rete 
processes, especially if these are long and bulbous as in some reactive conditions, or 
odontogenic residues (Fig. 27),28 but see sections 2.6 and 2.7. Examination of serial 
sections and assessment of keratinocytic atypia would be helpful. The integrity of the 
basement membrane could also be assessed in PAS-stained sections (Fig. 28). 
Caution should be exerted when there is subepithelial brisk and infiltrative 
inflammatory reaction (Fig. 17) as such reaction could effect disruption of the 
basement membrane and in turn compromise assessment. 
When we decide early invasion is present, we categorise this as 
microinvasive SCC if tumour is confined to the papillary lamina propria as defined by 
the depth of the rete processes, and superficially invasive if the tumour remains 
confined to the reticular (deep) lamina propria and not yet involving the submucosal 
tissues mentioned above (Figs. 29, 30). (Note: the term superficially invasive cannot 
be applied to tumours centred on the alveolar processes of the jaws or gingival 
mucosa due to the absence of a submucosa.) While the need for measuring the 
reconstructed tumour thickness (section 2.3) in cases of superficially invasive SCCs 
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is obvious, such measurement may be redundant in cases of microinvasive lesions. It 
seems, however, justified when the affected epithelium is of an increased thickness. 
If we are uncertain whether or not microinvasion has occurred in a 
background of severe dysplasia, proliferative or not, we report the histology as 
lacking unequivocal evidence of invasion or progressing to microinvasive SCC. In 
any case and pending on clinical judgement, such lesions could be treated similarly 
to microinvasive SCC since an incisional biopsy may not contain the most advanced 
part of the lesion. Alternatively, re-biopsy could be considered. 
It is a matter of dispute whether sialadenotropism (spreading of severe 
squamous epithelial dysplasia / carcinoma in-situ along the lining of collecting 
salivary ducts) (Figs. 31, 32) should be regarded as invasion,29,30 which is similar to 
the prognostic uncertainty regarding the extension of malignant melanoma along 
cutaneous adnexae. That the spreading is usually confined within the ductal lining, 
breaching of the ductal basement membrane and penetration of adjacent stroma 
being exceptional, contributes to the difficulty. Given the uncertainty, we recommend 
that the depth of its extent should be included in the histopathology report. On routine 
histology, ducts affected by sialadenotropism are usually distinct from frank infiltration 
of surface origin because, pending on the plane of sectioning, of the rounded shape 
and or linear arrangement of the ducts section profiles and of the variable 
discernment of constituents of the ductal lining (Figs. 32-34). Immunohistochemical 
contributions await exploration. Secondary involvement of major salivary ducts by 
OSCC should not be confused with sialadenotropism (Fig. 35). 
 
2.5 Vascular invasion 
 
Care is needed to distinguish retraction artefact from intravascular embolisation. 
Practically, vascular invasion occurs in thin-walled vessels (Fig. 36), whereas 
involvement of muscular vessels is rare (Figs. 37, 38). In accordance with breast 
pathologists,31 we identify vascular invasion only when tumour-cell aggregates are 
within clear spaces that are completely lined by endothelial cells (Fig. 36). 
Occasionally, microthrombi associated with tumour-cell aggregates (Fig. 39) could 
draw the attention of the pathologist to vascular invasion. It is usually difficult, and of 
little or no importance, trying to identify the involved thin-walled vessel as capillary or 
lymphatic. Special techniques (eg. staining for elastin) are of little use and the term 
lymphovascular invasion is used to convey this uncertainty.31 
 
2.6 Bone involvement 
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There are two problems. Firstly, in deciding whether or not the full thickness cortical 
plate is destroyed by tumour and hence leading to pathological categorization pT4.1 It 
is important to remember that the superior, occlusal aspect of the edentulous alveolar 
process may show atrophy and defects due to physiological remodelling following 
extraction of teeth.32 It is necessary to judge the depth of bone loss due to tumour in 
relation to the surrounding bone contour. This method is applicable to bone lesions of 
any shape including horizontal, vertical and saucer-like (Fig. 36). The second 
problem relates to unequivocal pT4 cases when the pattern of involvement should be 
recorded for prognostic purposes. Two patterns, erosive and infiltrative (Figs. 40, 41; 
also see Fig. 3 in Woolgar and Triantafyllou23), have been described,33-35 but in 
practice many cases show both. The region of bone showing the most advanced 
involvement, identified by radiography of the resection specimen prior to macroscopic 
dissection, should be histologically examined since the infiltrative pattern, if present, 
is more likely therein. As in other pathological assessments (section 2.3), the 
occurrence of the more unfavourable category is recorded. Tumour-bone interface is 
shown in Fig. 42. 
In the dentate jaw it is important to assess extension via periodontal ligament 
since we have seen tumour entering cancellous bone and marrow spaces via this 
route (Figs. 43, 44). 
Odontogenic vestiges found in marrow spaces of cancellous bone (Fig. 45),28 
should not be misdiagnosed as tumour. 
 
2.7 Pseudocarcinomatous hyperplasia and ‘benign perineural infiltration’ 
 
It is documented that reactive conditions may give rise to florid rete hyperplasia with 
frequent mitotic figures, and on masticatory mucosa, deep keratinisation with well-
formed keratin pearls - so called ‘pseudocarcinomatous (pseudoepitheliomatous) 
hyperplasia’, and this could be misdiagnosed as well-differentiated SCC particularly 
in incisional biopsies. An awareness of such conditions (Table 2) is important and 
histopathological diagnostic algorithms have been provided by 
dermatopathologists.36 
Of the conditions shown in Table 2, we would like to draw attention to the 
pseudocarcinomatous hyperplasia associated with transepithelial elimination. While 
dermatopathologists are appreciative of this process,37 oral and ENT pathologists 
may be less well so. We have repeatedly observed transepithelial elimination of small 
sequestra and fragments of cementum in intra-oral biopsies (Figs. 46, 47) and Odell 
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and Morgan38 have illustrated other calcified material similarly eliminated. Florid 
pseudocarcinomatous hyperplasia associated with transepithelial elimination of 
sequestra could account for old reports of SCC arising in a background of chronic 
osteomyelitis with draining fistula39 and for the ‘worrying features’ noted in 
consultation requests we have received and concerning biopsies from fractured jaws. 
Awareness of transepithelial elimination and the lack of cellular atypia and 
destruction of healthy bone usually enable a confident diagnosis. 
The histopathological diagnostic algorithms mentioned above are applicable 
in the mouth. Abenoza and Ackerman36 noted that hyperplastic adnexal lining 
contributes to cutaneous pseudocarcinomatous hyperplasia. Similarly involved 
collecting salivary ducts account for the depth of the proliferation in some oral 
pseudocarcinomatous hyperplasias. These are also lacking cellular atypia and 
tumour-induced stroma / desmoplasia (section 2.3), do not destroy host tissue and 
their epithelial arrangements are often elongated and angular contrasting with the 
often ‘rounded’, irregular tumour-cell aggregates of OSCC. The latter should not be, 
however, confused with lobular arrangements of atrophic, metaplastic salivary 
parenchyma, which characterise late stages of necrotising sialometaplasia (Fig. 48) 
(see also section 2.9). 
As regards keratoacanthoma (KA), we endorse an origin from proliferating 
infundibular epithelium40 and intra-oral examples could represent misdiagnosed 
carcinoma cuniculatum (Fig. 26). Similarly to mammary hyperplasias,41 ‘benign 
perineural infiltration’ has been reported in some KAs,42 but this needs to be re-
examined in the light of a possible continuum between KA and some well-
differentiated SCCs.2 
Except for KA, other examples of ‘benign perineural infiltration’, which could 
be misdiagnosed as OSCC, have been reported. This seems unjustly over-
emphasised. The clinical setting is not right, most of these examples occurring in the 
capsule of odontogenic cysts (Fig. 49) and in apical granulomas,43-46 whereas the 
epithelial parenchyma of Chievitz’s organ is situated between small nerves rather 
than infiltrating them (Fig. 50).47 
 
2.8 Lesions with a papillary exophytic component, proliferative verrucous 
leukoplakia (PVL) and squamoproliferative lesions 
 
The precise histological categorisation of mucosal lesions that include an exophytic 
growth component is a difficult and often encountered experience. Terms such as 
‘papillary’ and ‘verrucous’ are commonly used, but indiscriminately or rarely defined, 
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which results in confusion. There are no universally accepted definitions or 
differential diagnostic criteria. We use the term papillary for lesions showing true 
papillae, ie exophytic finger-like projections or mammillations with a fibrovascular 
core covered by proliferated surface epithelium, keratotic or not. We reserve the term 
‘verrucous’ for lesions showing a keratotic exophytic surface composed of sharp or 
blunt epithelial projections with keratin-filled invaginations (plugging), but without 
obvious fibrovascular cores. 
The term ‘papillary dysplasia’ or ‘atypical papillary hyperplasia’48 seems 
appropriate for papillary lesions with dysplastic features, wherein invasion is not 
detected. When a focus of invasion is detected in a papillary lesion, we use the term 
‘papillary SCC’ (Fig. 51). Lesions with a ‘verrucous’ surface may be verrucous 
carcinoma or show the conventional invasive growth pattern. We refer to the latter as 
‘SCC with an exoendophytic growth pattern’. 
The histological features of verrucous carcinoma, eg. verrucous surface (as 
defined above) and ‘elephant feet’-like downgrowth seeming to compress the 
underlying connective tissue and typically showing minimal cytological atypia, are 
widely known,38,49 but the diagnosis eventually depends on identifying the 
characteristic peripheral buttressing or shouldering (Fig. 52).20,50 The latter may be 
lacking in incisional biopsies and difficulties arise. Similar difficulties are experienced 
in incisional or excisional biopsies of clinically extensive ‘white’ lesions, which 
histologically show: 1) a ‘verrucous’ surface (as defined above); 2) increased 
epithelial thickness, evidence of proliferation with often peripheral mild atypia; and 3) 
a front advancing at more or less the same level and expanding, but confined to, the 
lamina propria. The first step in such instances is to exclude the presence of foci of 
conventional SCC with an obviously invasive growth pattern, which may be small and 
or multiple. If, after thorough sampling of the whole specimen, we become convinced 
that such foci are absent, we usually characterise the histology described above as a 
stage in the life history of PVL.51 We find PVL, envisaged as a continuum of lesions 
simultaneously occurring with or metachronously evolving into verrucous and / or 
conventional SCC, as a useful concept and we do not believe that sequential 
biopsies showing evidence of progression are required for its diagnosis. Also, we still 
use the term if basal cell hyperchromatism and other atypia are evident. Having 
reached a diagnosis of a PVL stage, it is essential that the pathologist alerts the 
clinician to the progressive nature of the lesion and recommend complete excision or 
close follow-up and re-biopsy. 
It now becomes convenient to introduce the concept of oral 
squamoproliferative lesion. We reserve this term for those occasions when incisional 
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biopsies (often of gingival lesions) show: 1) proliferation of oral epithelium, usually 
exoendophytic and resulting in variable epithelial thickness; 2) either papillary or 
verrucous exophytic component; 3) smoothly contoured, though irregular / 
asymmetrical and not pushing, endophytic component that advances at different 
levels of, but still confined to, a variably expanded lamina propria; 4) no evidence of 
frank invasion; and 5) variable dysplasia of deep keratinocytic layers or not. When 
the latter is present, the term dysplastic squamoproliferative lesion can be used. It 
could be argued that distinction from proliferative squamous epithelial dysplasia 
becomes blurred and we support the cautious use of squamoproliferative lesion with 
or without dysplasia, as a diagnosis. It is a last resort stratagem conveying that we 
are uncertain whether the lesion is malignant. The clinician has to be alerted to the 
need for mandatory follow-up as for PVL. Infection with candida is not uncommon 
and increases difficulties. 
Finally, the distinction between squamous cell papilloma, viral warts and 
lesions such as palatal papillomatosis and papillary dysplasia / papillary SCC should 
be straightforward since the former group should not exhibit atypia. Superficial 
biopsies can be problematic especially if the lesion is infected with candida and 
shows reactive nuclear changes. Consideration of the clinical history and features, 
such as size, is also important in preventing misdiagnoses. Features suggestive of a 
viral effect, such as koilocytic change or hypergranulosis are not useful as they may 
be seen in benign, pre-malignant and malignant epithelial proliferations. 
 
2.9 Adenosquamous carcinoma 
 
This histological subtype, except for interesting theoretical considerations (eg. origin 
from basal cells of surface epithelium that are capable of divergent differentiation, 
expression of different phenotypes rather than simultaneous malignant 
transformation of surface and glandular epithelium or collision tumour), is treated 
separately because of possible limitations in definition and difficulties in recognition. 
Two components, SCC (usually not well-differentiated) and adenocarcinoma, 
which remain distinct and separate is the usual requisite for the histological diagnosis 
of adenosquamous carcinoma. While the SCC component is superficial and may be 
in situ rather than invasive, the glandular component is usually within deeper parts of 
the tumour and shows formation of true luminal structures that should not 
misinterpreted as resulting from malignant acantholysis52 (see section 2.2). The 
structures, although usually small or collapsed and not cystic or rigid, are identified 
after diligent search and contain epithelial mucins demonstrable on AB pH 2.5-PAS 
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staining. Similarly to hybrid OSCCs, cervical node metastases of adenosquamous 
carcinoma (present in around 75% of cases) often consist wholly or predominantly of 
one component. 
Such definition of adenosquamous carcinoma implies that the deep 
component resembles a non-specific adenocarcinoma. We have, however, observed 
occasional, otherwise conventional, squamous cell carcinomas wherein deep 
components express non-keratinising cell phenotypes and architectural patterns (eg. 
cribriform) and / or features (eg. comedo-necrosis, collagenous spherulosis) seen in 
types of salivary carcinoma (eg. salivary duct carcinoma) (Figs. 53, 54) prompting the 
question whether the definition of adenosquamous carcinoma should be expanded or 
appropriately modified to include them. 
The presence of epithelial mucins in the lumens of adenosquamous 
carcinoma suggests that clones of tumour cells are able to produce and release 
mucosubstances. Often, such clones are represented in occasional cells found as 
individual units or small collections either in the lining of luminal spaces or within solid 
cellular aggregates. Synthetic and secretory processes in such cells are revealed by 
AB pH 2.5-PAS staining, but they may not be advanced enough to result in typical 
mucous phenotypes recognisable on routine histological staining. On the other hand, 
tumours showing histology of a conventional, usually pG2, SCC may contain 
individual or grouped cells with easily identified mucous or goblet-like appearance 
(Fig. 55). In these instances the pathologist has to decide whether such cells are 
normal tissue elements trapped within the growing tumour or innate neoplastic 
constituents. When there are grouped mucous cells in a lobular architecture, it is 
likely that they correspond to preserved minor salivary glandular lobules invaded by 
SCC (Fig. 56). When the mucous cells appear to be neoplastic, the histological 
differential diagnosis should include adenosquamous carcinoma as well as high-
grade mucoepidermoid carcinoma and SCC with mucous metaplasia. (The latter is 
poorly-described in the literature, but is theoretically possible and would be 
distinguished from high-grade mucoepidermoid carcinoma by assessing surface 
epithelial vs. subepithelial origin, centre of growth.) Detection of dysplastic oral 
surface epithelium and deep luminal spaces tip the scales in the direction of 
adenosquamous carcinoma, but these features could be absent in incisional 
biopsies. While reporting such biopsies, we note the possibilities and emphasise the 
academic rather than clinical significance of the uncertainty as these malignant 
lesions are behaving and treated similarly. In contrast to high-grade mucoepidermoid 
carcinoma and popular belief, we believe that the more common low- or 
intermediate-grade mucoepidermoid carcinomas are unlikely to be confused with 
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adenosquamous carcinoma. Their asymmetrically distributed cystic and solid 
aggregates comprising variable mixtures of cells showing mucous, clear, squamoid 
and simple phenotypes, and lack of keratin pearls are characteristic and instantly 
recognised. 
Malignant squamoproliferative lesions with neoplastic mucous or goblet cells 
should not be confused with the so-called clear-cell SCC. This clear-cell subtype has 
also been recognised in skin53 and refers to conventional SCCs wherein swathes and 
small groups of neoplastic keratinocytes rather than individual units show ‘empty’, 
vacuolated cytoplasm (Fig. 57). The ‘empty’ keratinocytes share a ‘clear’, pale 
phenotype with mucous or goblet cells and could simulate a classic signet-ring 
appearance (Fig. 57b), but they do not contain mucosubstances. Possibly, the ‘clear-
cell’ phenotype reflects a fixation artefact resulting in multiple small cytoplasmic 
‘vacuoles’,53 which eventually coalesce to form a single large vacuole that pushes the 
nucleus against the plasmalemma (Fig. 53c). 
The significance of preservation of a lobular architecture in distinguishing 
normal tissue from neoplastic elements has been noted above. This together with the 
lack of cellular atypia, are important features in recognising necrotising 
sialometaplasia (see section 2.7 and Fig. 48). 
 
2.10 Carcinoma within the connective / submucosal tissues without an obvious 
surface mucosal origin 
 
A biopsy may occasionally show an epithelial tumour within the lamina propria or 
submucosa that does not have an obvious origin from the overlying surface 
epithelium. If the tumour is a SCC, the probable explanation is that the biopsy is from 
an area of intact mucosa adjacent to a primary SCC and deeper sections may reveal 
surface origin or squamous epithelial dysplasia. If not, we usually comment in the 
report on the lack of an obvious surface origin and state that the appearances are 
consistent with an intra-oral primary arising at an adjacent site. In patients with 
recurrent SCC, submucosal or dermal nodules may be due to direct spread, non-
contiguous extension or vascular spread from a deep-seated focus of tumour. 
Metastasis to a facial lymph node should also be considered. The diagnosis of 
lymphatic metastases to the skin of the neck from deep-seated cervical node 
metastases is usually straightforward, particularly when the clinical history is known. 
If the features of an oral submucosal epithelial tumour nodule are not typical 
of SCC, the differential diagnosis includes salivary and odontogenic neoplasms and a 
metastatic deposit. An awareness of these possibilities and good knowledge of the 
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histological features of the full range of salivary and odontogenic neoplasms3 should 
prevent serious errors. Immunohistochemistry may be helpful in categorising 
suspected metastatic disease. 
 
2.11 Changes in intra-oral skin flaps 
 
Since the 1980s, free tissue transfer using vascularised skin-flaps such as the radial 
forearm flap has been a routine part of the management and rehabilitation of OSCC 
patients.54 At least 5% of patients go on to develop cancer at the junction of the skin-
flap and native oral mucosa.26 Over the years, we have seen increasing numbers of 
biopsies from regions of skin-flap remote from its junction with mucosa and the 
diagnosis has included adnexal tumour, seborrhoeic keratosis, hyperkeratotic plaque, 
chronic hyperplastic candidiasis (CHC), CHC with squamous dysplasia, squamous 
dysplasia, papillary dysplasia, Bowen’s disease (carcinoma in-situ) and SCC. 
Diagnosis of CHC can be difficult since its features in skin may be unfamiliar to oral 
pathologists used to seeing mucosal CHC. Generally, in cutaneous CHC, epidermal 
hyperplasia is associated with marked compact hyperorthokeratosis; subcorneal 
microabscesses are sparse and candidal hyphae lie haphazardly in large clumps 
within the superficial layers of keratinocytes.55 This ‘cutaneous reaction pattern’ is not 
seen in all cases; some biopsies show features more akin to mucosal CHC. Both 
patterns may be seen in the same biopsy and interpretation of the findings may be 
compounded by the presence of cellular and architectural atypia. Caution is needed 
when grading dysplasia in skin-flaps since the abnormal pattern of keratinisation is 
often striking and may lead to an erroneously high-grade categorisation if the 
pathologist is experienced in grading mucosal rather than cutaneous squamous 
dysplasia. Some patients have further biopsies after antifungal therapy and generally 
these show orthokeratosis and minimal, if any, dysplasia suggesting that the 
dysplasia was ‘reactive’. The biopsies diagnosed as Bowen’s disease showed 
features very similar to Bowen’s disease of skin of unexposed sites including spread 
down along pilosebaceous orifices and sharply demarcated margins. We have 
insufficient cases with prolonged follow-up to understand the aetiology and natural 
history of skin-flap lesions. However, a small number have progressed to invasive 
SCC, one showing the acantholytic subtype. Some, but not all, patients with 
dysplastic or carcinomatous lesions of the skin-flap have concomitant dysplasia of 
the oral mucosa and the aetiology and pathogenesis of the skin-flap lesions may 
differ in individual cases. Clearly, more studies showing the histological appearances 
of intra-oral skin flaps as they adapt to the oral environment (‘mucosalisation’)56 and 
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in disease are needed. When faced with a difficult case, it may be necessary to write 
a descriptive report explaining the findings and uncertainties and recommending 
mandatory follow-up with re-biopsy if there is ongoing concern. 
 
3. Pathological assessment of the intra-oral resection specimen 
 
Intra-oral resection specimens (Fig. 1) range from solely mucosa and underlying soft 
tissues through to complex en bloc resections of several anatomical areas or even 
organs such as a glossectomy en bloc with mandibulectomy and NDs. Surgical 
pathological anatomy texts such as Slootweg and de Groot57 provide basic 
instructions on handling specimens from the various anatomical areas together with 
diagrams showing recommended planes and directions for cutting the specimen. 
Here, we focus on procedures influencing pathological staging and prognosis, and 
mention practical tips that may be helpful. 
 
3.1 Presentation of the specimen 
 
Distortion of resection specimens can lead to poor orientation and incomplete or 
inaccurate identification of surgical margins. Some distortion is inevitable as different 
oral tissues shrink by different amounts during fixation of specimens.58,59 Thin 
specimens should be supported on card or pinned or sutured on to polystyrene or 
cork sheets and it is helpful if even large resection specimens including those 
containing bone are laid out and pinned in the correct anatomical position. The 
surgical staff should provide a simple line drawing or photograph showing the limits 
of the resection and marking, by ink or sutures, any areas of the margins, which are 
of concern or special interest. Care should be taken by the pathologist when inking 
the surgical margins - both peripheral and deep, bearing in mind that the deep aspect 
of large resections of the floor of mouth, may have been anatomically in contact with 
the tissues of nodal level I of the ND.60 Failure to recognise this anatomical 
relationship can lead to misinterpretation of the margin of clearance and confusion 
between the extent of direct spread of the primary tumour and extracapsular spread 
of metastatic tumour. 
 
3.2 Slicing the specimen 
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The pathologist should avoid sampling errors due to inadequate slicing and poor 
block selection by following a routine protocol with attention to detail. It is essential to 
slice the whole specimen ensuring that each slice is about 4 mm thick. Generally, the 
slices should be laid in the cassette to show the same face. However, it is important 
that each slice is inspected with the naked eye. It is not uncommon for tumours, 
particularly of the tongue, to show narrow streaks or tiny satellite islands well ahead 
of the main front (see Fig. 5 in Woolgar and Triantafyllou23) and such slices should be 
laid down to show these features. While cutting sections on the microtome, the 
pathology technicians should not discard early sections since narrow streaks / 
satellite islands can be easily cut through and it is advisable to save a ribbon of 
sections when something of special interest has been noted by the pathologist 
macroscopically. Whenever possible, large blocks that allow for large cross-sectional 
slices to be viewed intact should be made. However, complete slices of the specimen 
may be too large to fit into conventional cassettes (Fig. 23) and they need to be 
trimmed in a manner that allows reconstructions of the original slice and hence, 
accurate histological measurement of complete dimensions of the tumour (section 
2.3), features of the advancing tumour front, and also the mucosa, submucosal / 
deep and bone margins. Care is also needed during labelling of the cassettes to 
ensure accurate reconstruction. We find the use of line drawings useful for this 
purpose. 
 
3.3 Histological assessment 
 
While histologically assessing the surface aspect of the tumour, in superficial 
tumours in particular, it is important to distinguish between regions of invasive 
carcinoma from adjacent carcinoma in-situ, if present, since only the former is 
included in the measurement of the surface diameter for UICC TNM staging 
classification.24 In addition, it is essential that the complete area of the mucosal 
resection is carefully examined histologically, not just the surface of the index (first 
primary) tumour and its immediate periphery, since a multifocal origin cannot be 
excluded or there may be a synchronous smaller primary tumour (undiagnosed 
clinically) as seen in 9/11 of the resections with involved mucosal margins in our 
study of 301 consecutive resection specimens.23 
As regards the deep aspects of the tumour, it is essential that any streaks or 
satellite islands or tumour ahead of the main front, which may be involving nerves or 
vessels, are detected by systematic scanning of the whole specimen using a medium 
power objective so that these tumour foci are included in relevant measurements 
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(see section 2.3). Foci of lympho-mononuclear inflammatory cells ahead of the 
advancing front should prompt assessment of additional sections23 since they might 
reflect host reaction to a microsatellite (Fig. 25). However, the significance of such 
foci has not been investigated. 
It is important to be aware of the more commonly encountered routes of 
invasion and tumour extension.23 For example, once tumour escapes from the 
muscle of the tongue, it may spread within the loose areolar tissues of the floor of 
mouth.23 In tumours of the anterior or lateral border of tongue, it is not uncommon to 
see tumour emboli within vessels running in the superficial or deep vascular plexuses 
(Fig. 58). 
The status of the submucosal / deep and bone resection margin is recorded 
independently from the mucosal resection margin.1 In our study of surgical margins in 
OSCC resections,23 involved deep margins were more frequent in tumours of the 
maxillary alveolus (45%), retromolar region (38%) oropharynx (38%) and buccal 
mucosa (33%) than in tumours of the floor of mouth (19%), mandibular alveolus 
(17%) and oral tongue (11%). The buccal soft tissue margin overlying maxillary and 
mandibular resections can be particularly difficult to assess due to tight binding of 
soft tissue to bone resulting in difficulties in slicing the specimen and separating the 
soft tissues from bone without disrupting the integrity of advancing tumour front and 
surgical margin. Issues related to the assessment of bone involvement and the 
integrity of the cortical plates, have been discussed in section 2.6. When assessing 
the bone margins, particular attention should be paid to the base (deep margin) of 
mandibular rim resections and also periosteum at the anterior and posterior bone 
margins since together these accounted for over 50% of positive bone resection 
margins in our study.23 In the mandible, tumour involvement in relation to the inferior 
dental nerve should be assessed (Fig. 59). Spread along the nerve or within 
perineural spaces may be encountered in post-radiotherapy resections61 but in our 
experience, it is rarely seen in patients having primary surgery. 
 
4. Pathological assessment of NDs 
 
The terminology associated with NDs (Fig. 2) can be confusing. Multiple 
classifications are used,62 and as these are based mainly on clinical and surgical 
factors, they may be unfamiliar to the reporting pathologist. A clear appreciation of 
the expressions used at MDTs and on Pathology Request Forms is essential to avoid 
misunderstandings (Table 3). 
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4.1 Background knowledge 
 
Good knowledge of the anatomy of the cervical lymphatic system, and, in particular, 
the boundaries, approximate number and variations in size and shape of nodes, and 
principle drainage basin and afferent routes of the six main nodal levels that may be 
removed at ND is essential.60, 62 In addition, it is important to be aware of the other 
nodal groups, such as the facial, sublingual and lingual nodes, which are 
occasionally the site of metastases from intra-oral primaries.63 Also essential is an 
understanding of the life history of a metastasis within an individual lymph node from 
embolus to extracapsular spread (Fig. 60).62 
Misunderstandings and pitfalls related to the incorrect use of histopathological 
terminology can be avoided by thorough knowledge and strict application of the 
commonly used expressions (Table 4). 
Guidelines and protocols for specimen presentation and macroscopic 
assessment, harvesting and trimming of lymph nodes,1 summarised in Table 5, 
should be followed with care, audited and modified as necessary. 
 
4.2 Special considerations at anatomical level I 
 
The submandibular salivary gland, removed as part of level I, should be assessed. In 
the non-irradiated patient, the glandular parenchyma is rarely involved by direct 
spread from nodal metastases, and hence, processing a single representative slice is 
usually sufficient. Immunocompromised and irradiated patients may show 
widespread glandular involvement via direct extension from involved submandibular 
nodes and multiple slices may be necessary. In addition, the submandibular salivary 
gland can also be involved by direct spread of a large floor-of-mouth tumour. In this 
case, the macroscopic assessment and dissection can be difficult and the precise 
origin of the submandibular mass may remain uncertain. Problems in dissecting the 
mass are compounded when the mass is firmly fixed to the body of mandible. In this 
situation, we leave part of the tumour mass attached to the mandible and examine 
them en bloc following decalcification. 
 
4.3 Harvesting and trimming of lymph nodes 
 
During the macroscopic assessment of the fixed dissection, if enlarged nodes are 
visible on or bulging out of the surface of the specimen, the area should be inked to 
facilitate assessment of the surgical margins. Increasing the fixation time beyond 24 
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hours makes nodes more palpable. While lymph nodes are often perceived as ‘brown 
islands in a yellow sea’, small nodes particularly at levels IIB and V may resemble 
adipose tissue or loose connective tissue in colour. Although these nodes are 
palpable due to their firm consistency, it is advisable to process any uncertain 
material. Larger nodes (around 10 mm or more) should be bisected or sliced through 
the hilum. If there is obvious metastatic tumour, slicing and block selection must be 
designed to show the extent of any ECS. Some involved nodes / nodal masses may 
be cystic (see Fig. 10 in Woolgar and Triantafyllou62) and it is advisable to measure 
the maximum profile diameter of the node prior to cutting and collapse of the cyst 
lumen. If, on slicing, the node appears negative, all slices should be processed. Re-
slicing the bisected node at 90 degrees to create multiple hemispherical segments 
permits assessment of greater areas of the sub-capsular sinus - the likely site of ITCs 
and micrometastases. Salvage NDs are often distorted by fibrosis from previous 
surgery and or radiotherapy. Tumour and any residual nodes may not be 
macroscopically distinguishable from scar tissue and multiple slices of all doubtful 
tissues should be processed. 
 
4.4 Histological assessment of nodal metastases and extracapsular spread 
 
In the histological assessment of metastatic disease, stromal reaction (Fig. 20) is a 
useful feature to aid distinction between early metastasis and an embolus impacted 
in an intranodal thin-walled vessel. The histological profile diameter of tumour in each 
positive node needs to be determined with reasonable accuracy since it influences 
the pathological stage. When multiple foci of tumour are detected in a single node, 
the profile diameter of the deposit corresponds to that joining the most extremely 
opposite foci (see Fig. 12 in Woolgar and Triantafyllou62). This may be difficult when 
the tumour is arranged as ITCs or tiny islands, but measurements could be easier on 
sections stained for cytokeratin immunohistochemistry (Figs. 64, 65). 
Accurate detection of the presence and extent of ECS is important in post-
operative management and prognosis prediction.64,65 The extent of unequivocal ECS 
can be recorded by reference to the perinodal tissues and structures involved or by 
estimating the distance in mm from a reconstruction of the original position of the 
node capsule.62 ECS may be focal - involving only the hilum, for example - and the 
diagnosis of early ECS is often challenging. Subcapsular and peripherally located 
tumour may abut onto the node capsule and may be accompanied by desmoplasia. 
When this suspicious feature is seen in a single node and there is no obvious ECS 
elsewhere in the ND, then additional step and serial sections should be examined. If 
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these do not reveal unequivocal ECS, then it is probably safe to regard this as 
tumour confined to the node. If there is bulging of the node with a microscopic 
prominence of tumour or tumour stroma (see Fig. 17 in Woolgar and Triantafyllou62), 
we record this as ECS confined to the immediate pericapsular area. Emboli of tumour 
cells or ITC within the perinodal thin-walled vessels (see Fig. 20 in Woolgar and 
Triantafyllou62) or within the capsular sinuses do not constitute ECS but they should 
be noted since they have additional prognostic value. 
 
4.5 Soft-tissue tumour deposits 
 
Tumour nodules in the connective tissue of a lymph drainage area without 
histological evidence of residual lymph node are not uncommon. They may be 
detectable at the macroscopic dissection stage, but more often are only evident on 
histological assessment. These should be classified in the pN category if the nodule 
has the form and smooth outline of a lymph node, but regarded as discontinuous 
extensions or resulting from invasion of vascular walls if the nodule has an irregular 
outline.24 In such cases, other obvious nodes are likely to be involved by tumour and 
the pN status would have been already established. 
The number of positive nodes may be uncertain due to matting. However, a 
rough estimate of the number of nodes contributing to a matted mass is often 
possible and hence, conferring pN2b status. Failure to recognise that more than one 
node is contributing to a large metastatic deposit would probably not be a significant 
lapse since the likely stage would be pN2a/pN3 on account of the measured size. 
 
4.6 Procedural suggestions 
 
Inaccuracies in histological detection are unavoidable but should be reduced to a 
minimum by a meticulous routine, alertness and concentration. It is helpful to assess 
the microscope slide initially with the naked eye to see the number, size and location 
of nodal profiles, and to record any tumour deposits. Each slide should then be 
scanned at low power (Figs. 66, 67a). Particular attention should be paid to the nodal 
sinuses examining each nodal profile with medium power objectives (Fig. 67b). 
Suspicious areas should be examined with a high power objective to confirm 
epithelial elements (Figs. 67c, d). It is helpful to adopt the system of marking the slide 
label with a red dot when nodes or profiles are assessed as positive and adding an 
arrow to indicate presence of ECS. Such a simple system saves time when writing 
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the report and presenting the findings in a table62 and also, facilitates retrieval of 
positive nodes for MDTs or teaching sessions, etc. 
Errors due to histological misinterpretation can be minimised by experience 
and good knowledge of potential pitfalls. The more common potential errors and tips 
on how to avoid them are shown in Table 6. 
 
5. Pathological contributions to the prognosis of OSCC 
 
Histopathologically assessed features of the surgical resection specimen continue to 
provide information that is central to determining the post-operative treatment needs 
and prognosis for an individual patient. The features are briefly revisited here. For 
details, see Woolgar.66 
 




The reduction in 5 year survival for more posteriorly located tumours - oropharyngeal 
compared to oral cavity - had been recognised for many years67 and is probably due 
to the association between tumour site and occurrence of cervical node metastasis; 
pTN stage at presentation; histological grade and features of the advancing tumour 
front such as pattern of invasion, and peri- or endoneural and lymphovascular 
invasion; the surgeon’s ability to achieve clear resection margins and the occurrence 
of metachronous primary tumour.66 Within the oral cavity itself, the affect of site is 
less certain. It was not a significant independent factor in a recent (2008) study68 
involving 489 intra-oral cancer patients treated by primary surgery and it may be that 




The size of the tumour affects both the choice and outcome of treatment. In the 
aforementioned 2008 study,68 there were significant differences in overall survival in 
relation to clinical T stage and pathological tumour diameter and pT stage in two 
patient groups: surgery with and surgery without neck dissection. Although tumour 
diameter is used in UICC pT staging,24 tumour thickness is now recognised as a 
more accurate histological predictor of occult nodal metastasis, local recurrence and 
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survival.66 The correlation between tumour diameter and thickness tends to be 
poor.66 The ‘critical’ thickness is highly site dependent, but 4 mm is a useful average 
for OSCC with thicker tumours having a fourfold increased risk of nodal metastasis 
than thinner tumours.69 In predicting survival, the reconstructed thickness 
measurement, as defined in section 2.3, is robust. For example, in a 1999 study26 the 
tumours were from diverse sites within the mouth and oropharynx, yet the mean 
thickness in patients dying of or with cancer was twice that of survivors or patients 
dying free of cancer. 
 
5.1.3 Histological grade of conventional squamous cell carcinoma 
 
Generally, large studies report a correlation between WHO histological grade3 (see 
section 2.3) and survival and in the 2008 study,68 there was a significant difference in 
disease-specific and overall survival. The 5 year disease-specific survival was 89%, 
68% and 45% for pG1, pG2 and pG3 tumours, respectively (p<0.0001).68 However, 
WHO grade alone shows poor correlation with outcome in an individual patient66 
possibly because the system is poorly discriminating, most OSCCs being graded as 
pG2 (see section 2.3). The invasive front, multifactorial histological malignancy 
grading system, although open to similar criticisms (see section 2.3), it is reportedly 
more useful in predicting nodal metastasis, local recurrence and survival.66 The 
pattern of invasion which reflects cellular cohesion (see section 2.3) is the single 
most important feature and it has predictive value in the clinical setting.66 In addition, 
the pattern of invasion reflects in vitro markers of malignancy such as loss of contact 
inhibition, and tumour cell motility. 
 
5.1.4 Lymphovascular and peri- / endoneural invasion 
 
Both these factors show a significant association with tumour size, invasive front, 
multifactorial histological malignancy grading, and outcome in terms of nodal 
metastasis, status of resection margins, local recurrence and survival (Woolgar, 
2006).26,70 In the 2008 study,68 peri- or endoneural invasion was an independent 
predictor of all causes survival in Cox regression modelling. 
 
5.1.5 Bone invasion 
 
The UICC TNM staging classification categorises involvement of bone with 
penetration of the mandibular and maxillary cortical plate into cancellous bone and 
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marrow spaces as T4,24 but it is uncertain whether the consequent stage IVA status 





It has been reported that sialadenotropism is associated with increased local 
recurrence and further primary tumours,30 but see section 2.7. 
 
5.1.7 Involvement of overlying skin 
 
This is a grave prognostic sign. For example, involvement by direct spread and 
lymphatic spread are associated with median survival of only seven and three 
months, respectively.71 
 
5.1.8 Histological subtypes 
 
The prognosis of verrucous carcinoma and carcinoma cuniculatum is generally good 
since nodal metastases do not occur while adenosquamous carcinoma and basaloid 
squamous cell carcinoma are regarded of poor prognosis due to early regional and 
distant metastases,72,73 but see relevant comments in section 2.2. Assessment of the 
prognostic value of other subtypes is limited by inconsistent recognition and 
documentation. 
 
5.1.9 Histological status of the resection margins 
 
This is a robust prognosticator.66 In the 2008 study68, in Cox regression modelling, 
both margins and pN status were independent predictors of mortality at p<0.001. The 
relative risk of death ratio was 2.2 [1.4-3.5 confidence interval (CI)] for close and 3.4 
(2.1-5.6 CI) for involved margins in comparison to clear margins. 
 
5.2 Prognostic features related to the cervical (regional) lymph nodes 
 
The prognostic importance of the presence and extent of cervical lymph node 
metastasis has been recognised for many decades and several independent 
authorities have reported an association between outcome (in terms of regional 
recurrence and, or survival) and the features listed in Table 7.66 There is no general 
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agreement on which features are the best prognosticators and factors influencing the 
stringency of the pathological assessment probably explain, at least in part, the lack 
of consensus. The importance of pN status as an independent predictor of mortality 
in the 2008 study68 is clear. The relative risk of death was 2.2 (1.3-3.8 CI) for pN1 
and 4.8 (3.1-7.5 CI) for pN2-3 compared to pN0. The prognostic significance for 
micrometastases and ITCs is not known for OSCC, but studies of sentinel nodes74 
may provide an insight. 
 
5.3 Additional prognostic features 
 
Between 5-25% of OSCC patients have clinical evidence of distant (not locoregional) 
metastases within two years of the initial diagnosis.66 Pathological TNM stage pN2 or 
pN3, especially if ECS is present, are most at risk and 90% are dead within two 
years.64 
Local relapse due to a true recurrence occurs earlier and has a worse 
prognosis than relapse due to a metachronous primary tumour.26 In addition, relapse 
in the neck due to persistence or recurrence in the operated or irradiated field has a 
worse prognosis than relapse due to growth of occult metastases outside the original 
field of treatment or in the contra-lateral neck.26 
Both epithelial dysplasia peripheral to the primary tumour and an index 
tumour of multifocal origin (multiple separate foci of invasion within a larger region of 
epithelial dysplasia) are associated with an increased risk of serial primary tumours. 
Although the metachronous tumours are usually diagnosed when small, together with 
systemic metastases, they account for most of the disease-specific deaths occurring 




This article has addressed issues facing the diagnostic histopathologist during 
routine assessment of surgical material from OSCC patients. It is hoped that the 
practical approach taken, has highlighted commonly encountered questions and 
experiences, identified pitfalls and, when possible, offered tips and guidance. It is 
important to remember that the pathological assessment and generation of the final 
report involves staff from multiple disciplines. Detailed consideration of potential 
problems due to technical, secretarial and clerical errors is beyond the scope of the 
present article, save to point out that the pathologist is ultimately responsible for 
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establishing, overseeing and auditing laboratory standard operating procedures. The 
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Table 1 An index of the topics discussed as common questions, experiences and 
problems faced by the pathologist diagnosing and assessing incisional biopsies and 
surgical resections of primary OSCCs 
 
Topic Question, experience or problem 




Histological subtypes of OSCC 
 
Conventional  OSCC vs. subtype   
‘Pure’ vs. hybrid tumours   
‘Suspicious spindle cells’ 
Changes due to previous surgery or 
radiotherapy 
 
Grading systems of conventional 






Deep (unequivocal)  vs. superficial 




Microinvasive vs. superficially invasive SCC  










Criterion for pT4 status  
Erosive  vs. infiltrative pattern 
Spread via the periodontal ligament  
Benign odontogenic vestiges 
 
Pseudocarcinomatous hyperplasia  
and ‘benign’ perineural infiltration 
 
OSCC vs. pseudocarcinomatous 
hyperplasia vs. transepithelial elimination vs. 
sialometaplasia  




Lesions with a papillary exophytic 
component ‘, proliferative verrucous 
leukoplakia and squamoproliferative 
lesions 
 
Definitions including those of papillary and 
verrucous 
Verrucous vs. papillary vs. exoendophytic 
conventional SCC 
 
Adenosquamous carcinoma  
 
Assessment of ‘glandular’ elements Clear-
cell SCC 
Sialdenotropism vs. hyperplastic salivary 
ducts vs. sialometaplasia 
 
Carcinoma within the connective  / 
submucosal tissues without an 









Table 2 Conditions that may be accompanied by pseudocarcinomatous hyperplasia 
 
1. Granular cell tumour 
2. Necrotising sialometaplasia 
3. Chronic inflammation and mild chronic trauma 
4. Denture-induced fibroepithelial hyperplasia 
5. Palatal papillary hyperplasia 
6. Hypertrophic lichen planus 
7. Chronic discoid lupus erythematosus 
8. Chronic hyperplastic candidiasis 
9. Blastomycosis 
10. Keratoacanthoma 
11. Wegener’s granulomatosis 




Table 3 Terminology used to describe neck dissections (for details see Woolgar and 
Triantafyllou, 2007) 
 
Basis of classification Categories 




Simultaneous with resection of primary tumour; delayed 
 
Surgical relationship to 
primary tumour resection 
 








Radical (classical); extended radical; function-preserving; 
comprehensive (modified radical, Bocca); selective; 
supra-omohyoid; anterolateral 
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Table 4 Definition of terms used in pathological staging of NDs 
 
Term Definition 
Isolated tumour cells 
(ITCs) (Figs. 61-63) 
In any single node, collections of tumour cells totalling not 
more than 0.2 mm in greatest dimension (seen in HE-stained 
or on immunohistochemistry);63 they could be microemboli in 
perinodal vessels or in nodal sinuses or stroma 
Micrometastasis In any single node, tumour deposits confined within the nodal 
capsule, measuring between 0.2 and 2 mm24 and usually 
showing evidence of successful settling and growth (mitotic 
activity, stromal reaction)62 
Conventional 
metastasis 








In most cases, metastatic tumour develops initially in one or 
more lymph nodes draining the lymphatic basin of the primary 
tumour and then progresses in an ‘overflow’ fashion to 
produce an ‘inverted-cone’ shape63 
Skip metastases Metastases at non-contiguous nodal levels such as levels I 
and IV63 
‘Peppering’ ITCs or micrometastases in multiple nodes in the absence of 
a conventional metastasis63 
Extracapsular 
spread (ECS) 
Tumour infiltrating beyond the node capsule 
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Table 5 Guidelines for the pathological assessment of NDs, potential pitfalls and 
possible solutions 
 
In theatre after operation: 
1. Label the centre of each anatomical nodal group with tags or sutures and pin 
or suture specimen onto a polystyrene or cork board in correct anatomical 
position avoiding over-tight sutures (risk of poor fixation and tearing of 
tissues); alternatively, divide ND into its component anatomical levels (taking 
care not to disruption the integrity of the primary tumour resection) and place 
each level in a separate container 
2. Check the specimen is fully immersed in fixative (10% buffered formalin) 
3. Submit additional nodal groups in separate labelled container 
4. Give complete accurate details on the Pathology Request Form using 
waterproof ink (patient details, type of primary tumour resection and neck 
dissection, key to tags, and a line diagram or photograph) 
5. Label specimen container with matching patient details 
In laboratory: 
1. Search the soft tissues of the fixed specimen and identify all lymph nodes >3-
4 mm by observation and palpation 
2. Harvest the nodes (with their adjacent fibro-adipose tissue attached) from 
within each anatomical level and block out in labelled cassettes, slicing larger 
nodes; position of nodes could be indicated on line diagram or photo; 
alternatively, nodes could be harvested from all anatomical levels prior to 
blocking out, but take extra care over preserving nodes in separate groups 
corresponding to the levels 
3. Process by standard histological methods, and stain with HE 
4. Histological assessment of a single HE-stained section from each block 
5. Step / serial sections and / or immunohistochemistry in selected cases 
(micrometastasis versus conventional metastasis; extent of ECS; to 
investigate suspicious areas, etc) 
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Table 6 Potential pitfalls in histological interpretation and possible solutions (for 
illustrations, unless otherwise noted. see Woolgar and Triantafyllou62) 
 
Pitfall Solution 
Reactive changes versus metastasis  
Sinus histiocytosis Sinus macrophages are non-cohesive, 
pale stained, no mitotic figures; 
eosinophils may be associated with 
tumour deposits (Figs. 67d, 68a, b, Fig. 
69a, b); immunohistochemistry for 
cytokeratins rarely required (Figs 68c, 
69c) 
Vascular transformation of sinuses Florid early fibrosis and newly formed 
thin-walled vessels; care is needed to 
distinguish from neo-vascularisation 
evoked by a tumour deposit 
Changes in germinal centres Immunohistochemistry for cytokeratins 
Hyaline change within lymphoid 
parenchyma 
Not attributable to amyloid or scirrhous 
stroma of tumour deposit  
Granulomatous reactions: 
sarcoidal / immunological reaction to 
drained tumour products; foreign-body 
granulomata to small metastasis and / 
keratin deposit (eg. post-radiotherapy); 
concurrent granulomatous disease, eg. 
tuberculosis 
Immunohistochemistry for cytokeratins 
and macrophage markers plus clinical 
history, etc 
Benign cellular inclusions  
Salivary inclusions Uni- / bilayered duct-like structures lined 
by simple or oncocytoid epithelium 
Thyroid follicles More likely at levels III / IV 
Naevus cell nests Immunohistochemistry 
Flushing of nodal sinuses at multiple 
anatomical levels with malignant 
epithelial cells versus sinus histiocytosis 
May be mistaken as sinus histiocytosis; 
immunohistochemistry for cytokeratins; 
seen in around 1% of positive NDs63  
Cystic metastases versus branchial cyst 
and primary branchial carcinoma 
Age < or > 40 yrs; process complete 
cyst; examine step serial sections for 
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cytological atypia / obvious SCC; 
clinicopathological correlation 
Failure to recognise a subtype of SCC   
Confusion between acantholytic SCC 
and adenocarcinoma 
Awareness and AB pH 2.5-PAS 
Confusion between spindle cell SCC and 
other spindle cell neoplasms or stromal 
reactions 
Awareness and immunohistochemistry 
Hybrid SCC showing different cellular 
phenotypes 
Awareness that metastasis may consist 
of a single cellular phenotype 
Concurrent metastasis and leukaemia / 
lymphoma (double / dual pathology’) 
Awareness; patients with leukaemia / 
lymphoma often show multiple 
metastases in multiple levels; effacement 
of nodal architecture / loss of follicles by 





Table 7 Prognostic features related to the regional lymph nodes (for details, see 
Woolgar, 2006) 
 
1. Metastatic status - nodal metastasis present versus absent 
2. Laterality of positive nodes 
3. Number of positive nodes 
4. Size of metastatic deposit(s) 
5. Anatomical level of involvement 
6. Extracapsular spread 
7. Embolisation / permeation of perinodal lymphatics 





Note: Unless otherwise specified, the photomicrographs in this article are from sections of 
routinely processed tissue, which were stained with haematoxylin and eosin (HE); it was not 
deemed necessary to give objective magnifications. Figure 1 Resection of the anterior 
maxilla for an ulcerated SCC centred on the anterior edentulous alveolar process and 
extending to hard palate and vestibule. An ulcerated, satellite nodule is seen (arrow). Figure 
2 Resection of anterior tongue (asterisk), floor of mouth (not seen) and mandible (arrow), 
which is in continuity with bilateral neck dissections. Figure 3 Acantholytic OSCC. Section 
profiles of, at least, five pseudolumens are seen. The central, larger and somewhat collapsed 
pseudolumen has an irregular contour and contains ‘acantholytic’ cells. Some of the latter are 
rounded with deeply-staining nuclei, which suggests apoptosis. Whether apoptosis results in 
or is secondary to malignant acantholysis is speculative. Note the single (‘basal’) layer of 
malignant keratinocytes (arrowhead), which partly surrounds the pseudolumen and faces the 
stroma. Figure 4 Immunohistochemistry for MNF116 decorates a small collection of non-
cohesive malignant keratinocytes at the advancing front of an OSCC. Although non-cohesive, 
the cells appear ‘grouped’ and not dispersed (compare with Fig. 15). This was an isolated 
finding suggesting a focally expressed loss of cohesion; alternatively the collection could 
reflect an early stage in the clonal expansion of a non-cohesive cell. Immunohistochemical 
double staining for cytokeratins and for cell-cycle markers could be useful in exploring these 
possibilities. Figure 5 From an incisional biopsy diagnosed as basaloid OSCC. Except for 
easily identified palisading, the peripheral tumour cells are reversely polarised (away from 
stroma nuclei) and show subnuclear ‘vacuolation’ (arrowhead); this emphasises similarities to 
ameloblastoma. Assessment of the excisional specimen showed that the bulk of the tumour 
consisted of conventional SCC. Figure 6 Recurrent OSCC showing mixed squamous (large, 
polygonal or spindled with abundant eosinophilic cytoplasm and pleomorphic nuclei) and 
basaloid (small, haematoxyphilic with indistinct borders and bland nuclei) phenotypes (a); the 
phenotypes are further distinguished by immunohistochemistry for AE1/AE3, which selectively 
stains squamous cells (b). 
 
Plate 2 
Figure 7 Typical spindle cell carcinoma. The arrows indicate two angular tumour cells in 
mitosis (a); immunostaining for SMA showed myofibroblastic reaction in other regions of the 
tumour (b). The proliferated myofibroblasts are selectively stained and easily distinguished 
from the unstained tumour cells (T); the arrow indicates an enlarged ‘epithelioid’ tumour cell. 
Figure 8 Myofibroblasts in the stroma of a conventional SCC. Note their abundant cytoplasm 
and ‘rigid’ appearances (arrows); the arrowhead indicates an islet of malignant keratinocytes. 
Figure 9 Nasopharyngeal-type phenotypes in an OSCC. Figure 10 An ulcerated endophytic 
transitional-type carcinoma at the lateral border of the tongue (a); that the tumour was 
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associated with lymphoid aggregates (not seen on this magnification) suggests that it arose in 
the lingual tonsil; typical ribbons (b) and ‘vertical’ orientation of peripheral tumour cells (c). 
Figure 11 An ulcerated, endophytic, hybrid, squamous (S) and transitional-type (T) carcinoma 
(a). Note the markedly asymmetrical silhouette of the tumour. The area enclosed in rectangle 
is magnified in (b) to show eosinophilic (lower part of the photomicrograph) and 
haematoxyphilic (upper part of the photomicrograph) components. Figure 12 Special staining 
(Masson-Fontana) shows dendritic melanocytes, one of which is indicated by the arrow, and 
variable hyperpigmentation of malignant keratinocytes in a pigmented OSCC. 
 
Plate 3 
Figure 13 Brisk non-infiltrative inflammatory reaction in OSCC. Note the islets of malignant 
keratinocytes at the advancing front (type-III pattern of invasion); one islet is indicated by the 
arrow; nuclear aberrations are seen. Figure 14 The arrows indicate malignant keratinocytes 
that have lost cohesion at the ‘tip’ of an infiltrating column, possibly an ‘early’ type-IV pattern 
of invasion. In contrast with Fig. 4, this was not an isolated finding. Figure 15 Advanced type-
IV pattern of invasion. There is asymmetrical, widespread distribution of malignant 
keratinocytes that are infiltrating as individual units; two of them are indicated by arrows. 
(Compare with Fig. 4.) Inflammatory reaction is patchy. Figure 16 Individual, non-cohesive 
malignant keratinocytes and variably dyscohesive cords and islets are appreciated on 
immunohistochemistry for MNF116. Figure 17 Brisk and infiltrative inflammatory reaction in 
OSCC; many tumour cells underwent apoptosis and appear as glassy, rounded, eosinophilic 
(‘colloid’) bodies. Figure 18 Brisk inflammatory reaction in OSCC, which is enriched with 
eosinophils. Figure 19 Typical desmoplastic stroma (S) in OSCC. Note the absence of 
inflammatory cells and the sheathing of tumour cords and islets by stromal cells; this suggests 
that the latter are newly-formed and not pre-existing.
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 Figure 20 The inset shows section 
profiles of a cervical lymph node, one of which shows cystic SCC metastasis with induced 
stroma. Viable tumour and stroma project into the ‘cyst lumen’ in a drumstick-like 
configuration. This is better appreciated on higher magnification. The pale / ‘oedematous’ 
appearance of the stroma (S) is attributable to accumulation of glycosaminoglycans. 
 
Plate 4 
Figure 21 Endo- (arrow) and perineural (arrowheads) invasion in OSCC. Figure 22 Section 
from a frontal slice cut through the centre of an ulcerated endophytic SCC on the lateral 
border of the tongue; s, t and d indicate the supero-inferior surface diameter, reconstructed 
thickness and distance of the tumour from the deep excision margin respectively. The inferior 
mucosal (floor-of-mouth) margin appears involved (< 1.0 mm) (arrowhead). The superior 
mucosal (dorsal lingual) margin is free from tumour. Figure 23 Cut surface of a markedly 
asymmetrical, ulcerated, solid, endophytic OSCC with satellite coin-shaped nodules. The 
maximum diameter of the tumour, which corresponds to the line segment, should be recorded 
prior to further slicing since its reconstruction from the histological sections of the slices would 
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be an approximate. Figure 24 Variably sized, rounded islands consisting of well-differentiated 
stratified squamous epithelium with variable patterns of central keratinisation (I1-I6), are seen 
below an expanded and fibrotic lamina propria (asterisk) and surround salivary glandular 
elements (G). This qualifies as unequivocal invasion. Further support for the tumoral nature of 
the islands is given by their larger size and wider distribution than salivary lobules (compare 
with Fig. 48) and by the retraction artefact (arrow) seen between the island I4 and adjacent 
stroma. The well differentiated epithelium of I1- I6 also excludes sialadenotropism (see Fig. 
33). The surface oral epithelium (upper left part of the photomicrograph) has proliferated. 
Figure 25 There is unequivocal invasion (arrowhead) deeply in the submucosal fat below 
severely dysplastic oral epithelium (E). Although the invasive elements, shown at higher 
magnification in the inset, could be missed on casual inspection because of their small size, 
the lymphoid infiltrate associated with them should draw the attention of the pathologist. 
Figure 26 Step-section profiles of intra-oral carcinoma cuniculatum. The profile indicated by 
the arrow appears crateriform / cup-shaped and ‘pushing’ the submucosal skeletal muscle. 
However, invasion of the latter was detected in other profiles. Figure 27 Biopsy from the 
alveolar mucosa. Three rounded epithelial islets of ‘clear’ / pale appearance, presumably 
odontogenic, are seen in the expanded and fibrotic lamina propria. Amalgam tattooing is 
discernible in the lower right part of the picture. Figure 28 A focus of microinvasion 
(arrowhead) as appreciated in a section stained with PAS-H. It is unlikely that the absence of 
basement membrane reflects tangential sectioning. 
 
Plate 5 
Figure 29 Superficially invasive OSCC. The advancing front of the tumour (arrowhead) is 
above the submucosal skeletal muscle fibres (M). Note the hyperaemic capillary-sized 
vessels, a suggestion of neovascularisation, around the front. Figure 30 In comparison to Fig. 
29, this superficially invasive OSCC penetrates deeper, but it is still confined to an expanded 
lamina propria and the musculature (M) is not involved. Figure 31 Step-section profiles of 
salivary ducts (arrows) affected by sialadenotropism. Figure 32 Severe squamous epithelial 
dysplasia / carcinoma in-situ spreads from surface oral epithelium seen in the upper left part 
of the photomicrograph to involve the medial part of a collecting salivary duct. Figure 33 
Sialadenotropism has resulted in expansion of a transversely sectioned collecting duct (DS). 
Possibly the markedly thickened, dysplastic lining of DS effected partial obstruction and 
adjacent distal ductal segments (D1, D2), which lead from glandular lobules (G1, G2), became 
thus ectatic. Compare the rounded profile of DS with the irregularly dilated D1 and D2. 
Inflammatory reaction (asterisk) partly surrounds DS, but invasion is not seen. Figure 34 
Transversely sectioned collecting salivary duct partly affected by sialadenotropism. The 
dysplastic region is thickened and bulges into the lumen (L), but it is still covered by normal 
cylindrical adluminal cells. Note the eosinophilic cytoplasm of the latter. Figure 35 SCC 
involves Wharton’s duct and becomes exposed to the lumen. Figure 36 Section profiles 
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(arrowheads) of an apparently tortuous, subepithelial lymphatic vessel are permeated by 
OSCC. The arrow indicates the possible site where tumour penetrates the vessel. 
 
Plate 6 
Figure 37 Tumour embolus (arrow) in a large arteriole subadjacent to the advancing front of 
an OSCC. Figure 38 Non-cohesive OSCC (T) destroys the wall of a muscular vessel. Figure 
39 A slender column of largely cohesive malignant keratinocytes invades a thin-walled vessel. 
The invasion could be missed on casual inspection save for the fibrinous clot (arrow), which 
has formed on the ‘tip’ of the penetrating column. Figure 40 An exoendophytic SCC (T) of the 
retromolar region has caused erosion of the underlying cortex and exposure of cancellous 
bone. The margins of the erosion are indicated by the arrows. Figure 41 Infiltration of jaw 
cortex by SCC. Note the partial destruction of a Haversian system (H). Figure 42 SCC-bone 
interface. Tumour elements (arrowheads) at a distance from bone evoke osteoclastic 
resorption, one osteoclast being indicated by the arrow (a); the osteoclastic resoprption has 
subsided and tumour elements (arrowheads) are close to the bone surface (b). Figure 43 A 
SCC (T) of the alveolar process penetrates the periodontal ligament (arrow) and focally 
destroys a tooth (arrowhead).  
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Figure 44 SCC (T) that begins to infiltrate the periodontal ligament between alveolar bone (B) 
and cementum (C). Figure 45 Two ovoid islets of odontogenic epithelium are present in the 
fibrous stroma filling inter-trabecular spaces of cancellous bone. Figure 46 Transepithelial 
elimination of a small sequestrum (arrow). Figure 47 Downward growth of an epithelial 
column (asterisk) is seen at the margin of an ulceration (U), which is involved with elimination 
of a fragment of cementum (area enclosed in the rectangle) (a); the area is magnified to show 
the bland features of the proliferated epithelium (b). Figure 48 Necrotising sialometaplasia. 
Ulceration (U), presumably deep, exposes a collection of solid, mitotically inactive, squamoid 
islets (arrow), presumably submucosal. Although lumens are not seen, the islets are not 
dispersed, being grouped in a ‘lobular’ arrangement. This assists in their confident 
identification as metaplastic salivary parenchyma. Compare with Fig. 24. Figure 49 Two 
benign neuro-epithelial composites (arrows) in the capsule of a dentigerous cyst. The lumen 
and lining of the cyst are not shown here. Figure 50 Fibro-fatty tissue contains the 
transversely sectioned profiles of small nerve fascicles (arrow) and Chievitz’s organ (right part 
of the photomicrograph). The epithelial parenchyma (P), cellular stroma (S) and capsule (C) 
of the latter can be seen. Note that the nerve fascicles are situated outside the organ. The 
stroma of the organ contains myelinated fibres, not seen at this magnification, but these 
remain as individual units and are not arranged as fascicles. The appearances do not 




Figure 51 Section profiles of papillary squamous cell carcinoma. The exophytic part of the 
tumour shows asymmetrically distributed fronds; the endophytic part is irregular and 
penetrates at different levels (arrows). Compare with Fig. 52. Figure 52 Section profiles of 
verrucous carcinoma. In comparison with Fig. 51, the tumour advances at more or less the 
same level. This is highlighted by the banded and parallel to the surface inflammatory 
reaction (arrowhead) (a); shouldering is present (arrows) (b). Figure 53 While elements of 
conventional SCC are present in the left half of the photomicrograph, cribriform arrangements 
are seen in the right, above a collecting salivary duct (a); elsewhere, central comedo-necrosis 
(C) affects rounded islands of non-keratinising carcinomatous cells (b). Figure 54 The 
superficial part of a carcinoma arising from dysplastic oral surface epithelium (E) shows 
bands of malignant keratinocytes associated with hyaline material (arrow) (a); the deep part of 
the carcinoma shows rounded non-keratinising islands with hyaline droplets (arrow), which 
resemble those seen in adenoid cystic carcinoma (b). 
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Figure 55 Areas in an otherwise conventional OSCC, show small lumens (L) and  mucus-
producing cells with characteristic haematoxyphilic cytoplasm (arrows), which occur as 
collections or isolated (a, b). Special staining (PAS-H) decorates the mucous cells and shows 
neutral mucosubstances in lumens (indicated by arrow and L) (c, d, e). Note the differences in 
mucosubstance content between the cells surrounding the lumens in (d) and (e). Figure 56 
Minor salivary gland overrun by SCC. Palely-stained mucous tubulo-acini and a small duct 
(arrow) are easily identified. Figure 57 Large ovoid islands of clear-cell SCC are impinging on 
oral surface epithelium (a); unilocular cytoplasmic ‘vacuoles’ and ‘signet-ring’ phenotypes 




Figure 58 The inset shows section of a slice cut from a resection for SCC (T) of the lateral 
border of tongue. The area enclosed in the rectangle has been magnified to show invasion 
(arrowhead) ahead of the main tumour, probably an embolus in the deep vascular plexus. 
The arrows indicate ectatic thin-walled elements of the superficial vascular plexus. Figure 59 
Section of a decalcified mandibular slice shows transverse profile of the inferior dental nerve. 
One of the constituent fascicles (arrow) shows endo- and perineural invasion, magnified in the 
inset. SCC is present in the upper left corner. Figure 60 OSCC emboli in capsular lymphatics 
of a cervical lymph nose. Established metastasis in the nodal parenchyma is seen in the 
upper part of the photomicrograph. The arrow indicates valves of a lymphatic. Figure 61 and 
Figure 62 show ITCs (arrows) in cervical lymph nodes. The ITCs are larger than the adjacent 
small lymphocytes, show a somewhat irregular / angular nuclear contour, and have 
eosinophilic nucleoli and cytoplasm. By contrast immunoblasts are usually rounded and 
haematoxyphilic. Figure 63 ITC (arrow) in cervical lymph node, detected on 34BE12 
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immunostaining. Diffusion of the immunoreaction product to adjacent lymphocytes has 
occurred. Figure 64 Immunostaining for MNF116 highlights non-cohesive malignant 
keratinocytes in a cervical lymph node, which could be difficult to detect on routine histology. 
Figure 65 Immunostaining for cytokeratins, here 34BE12, facilitates measuring the maximum 
diameter (line segment) of dyscohesive OSCC cervical metastases. 
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Figure 66 Section profiles of bisected cervical lymph node with instantly recognised 
metastasis (arrows). The nodal halves had not been laid in the cassette to show the same 
face - hence, the different appearance of the metastasis profiles. The tumour deposits consist 
of heavily keratinised SCC and their maximum diameter can be easily measured. H indicates 
the hilum of the node. Figure 67 In contrast to Fig. 66, the section profiles of this node do not 
show obvious metastases at scanning magnification (a); the nodal sinuses are, however, 
expanded and filled with ‘compact’ eosinophilic cellular masses (b); this together with the 
keratin pearl (arrow) should alert the pathologist. Examination with a high-power objective of 
other ‘suspicious’ regions, for example the area enclosed in the rectangle, confirms SCC. The 
cytology of the larger malignant keratinocytes (arrowheads), as described in Figs 61 and 62, 
and the association with eosinophils (arrows) are characteristic (c, d). Figure 68 and Figure 
69 Features of sinus histiocytosis (Fig. 68) and metastasis of non-keratinising SCC (Fig. 69) 
are shown at the same magnification for comparison. The irregularly contoured, ‘loose’ and 
heterogeneous / mixed with lymphoid cells histiocytic infiltrate (Fig. 68a) contrasts with the 
more ‘compact’ and homogeneous tumour deposit (T) (Fig. 69a). 
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Figure 68 and Figure 69 (continued) The differences in looseness and homogeneity between 
sinus histiocytosis (Fig. 68b) and metastasis (Fig. 69b) are better appreciated on higher 
magnification; the arrows indicate a cleaved nucleus in the reactive condition and a mitosis in 
the metastasis. Immunohistochemistry for the CD68 antigen decorates macrophages in the 
reactive condition (Fig. 68c) and metastasis (Fig. 69c); while macrophages in the loose 
microenvironment of sinus histiocytosis appear plump and rounded, those squeezing against 
the unstained tumour cells (T) appear elongated. Figure 70 Example of dual pathology. The 
asterisk indicates a subcapsular deposit of non-keratinising OSCC in a cervical lymph node 
(a); sections profiles of the node containing the deposit do not show obvious follicles (b), 
which should prompt a closer examination of the lymphoid parenchyma itself. (For 
comparison with Fig. 70b, Fig. 70c shows a merely reactive lymph node with obvious 
follicles.) On higher magnification, effacement of nodal architecture by chronic lymphocytic 
leukaemia / small lymphocytic lymphoma is seen (d). This was confirmed by 
immunohistochemistry (e). Metastases of SCC were found in multiple cervical nodes (levels 
II, III and IV) of this patient because of the compromised immune system. 
